About This EventADMA Biologics, Inc. (Nasdaq: ADMA), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, visits the ...

About This EventArtiva Biotherapeutics (Nasdaq: ARTV), visits the Nasdaq MarketSite in Times Square. Artiva is a clinical-stage biotechnology company whose mission is to develop effective, safe, and ...

Meta's operating performance has been incredibly strong over the past year, thanks partly to its investments in AI, so its ...

Nvidia owns a 7% stake in CoreWeave, and made it possible for the young company to be the first to launch its latest GPUs. In ...

Palantir's expansion into commercial markets has boosted its business. The stock has been on a tear since the start of 2024.

One stock that managed to outmaneuver the various headwinds torturing the markets throughout the year, however, is data ...

Google parent Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) looks like an absolute steal compared to Palantir. While Palantir's forward price-to-earnings ratio is a jaw-dropping 256.4, Alphabet's shares ...

Although Alibaba stock looks reasonably priced, Amazon's lower business risk from the U.S.-China tensions gives it the edge ...

For mutual funds, investors send checks to the asset manager, which are invested by the portfolio manager at the end of the day. The investors get “units” of the fund at the end-of-day unit price, ...

Uber's stock has been on a tear in 2025. Shares are up over 55% through July 3. Even so, as the chart shows, Uber's P/E ratio ...

With shares down 21% year to date, Tesla (NASDAQ: TSLA) is reeling from a combination of weakening electric vehicle (EV) ...